Open, noncomparative trial of multidrug regimens containing clarithromycin and rifabutin administered three times per week for the treatment of M. [Mycobacterium] avium complex lung disease
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
At a glance
- Drugs Clarithromycin (Primary) ; Rifabutin (Primary)
- Indications Mycobacterium avium complex infections
- Focus Therapeutic Use
- 18 May 2017 Status changed from active, no longer recruiting to completed.
- 15 Feb 2008 New trial record.